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A B S T R A C T
Calcium signalling through store-operated calcium (SOC) entry is of crucial importance for T-cell activation and
the adaptive immune response. This entry occurs via the prototypic Ca2+ release-activated Ca2+ (CRAC)
channel. STIM1, a key molecular component of this process, is located in the membrane of the endoplasmic
reticulum (ER) and is initially activated upon Ca2+ store depletion. This activation signal is transmitted to the
plasma membrane via a direct physical interaction that takes place between STIM1 and the highly Ca2+-selective
ion channel Orai1. The activation of STIM1 induces an extended cytosolic conformation. This, in turn, exposes
the CAD/SOAR domain and leads to the formation of STIM1 oligomers. In this study, we focused on a small
helical segment (STIM1 α3, aa 400–403), which is located within the CAD/SOAR domain. We determined this
segment’s speciﬁc functional role in terms of STIM1 activation and Orai1 gating. The STIM1 α3 domain appears
not essential for STIM1 to interact with Orai1. Instead, it represents a key domain that conveys STIM1 inter-
action into Orai1 channel gating. The results of cysteine crosslinking experiments revealed the close proximity of
STIM1 α3 to a region within Orai1, which was located at the cytosolic extension of transmembrane helix 3,
forming a STIM1-Orai1 gating interface (SOGI). We suggest that the interplay between STIM1 α3 and Orai1 TM3
allows STIM1 coupling to be transmitted into physiological CRAC channel activation.
1. Introduction
Calcium signalling that occurs through store-operated calcium
(SOC) entry is crucially important for T-cell activation and mast cell
degranulation. The CRAC channel pathway is one of the most promi-
nent calcium signalling routes. CRAC entry is initiated by the depletion
of the endoplasmic reticulum (ER) calcium stores. This occurs when the
second messenger molecule inositol-1,4,5-triphosphate (IP3) binds to
IP3-receptors. In turn, this signal is transmitted to plasma membrane
(PM) resident Ca2+ channels and promotes Ca2+ entry [1]. When the
stromal interaction molecule 1 (STIM1) and Orai1 were identiﬁed as
the main molecular components of this mechanism, a milestone was
reached in the ﬁeld of calcium signalling [2–8].
STIM1 represents the ER-located Ca2+ sensor, and Orai1 forms a
highly Ca2+-selective channel, which is located in the PM. In resting
cells, STIM1 is uniformly distributed throughout the ER membrane and
has a stable connection to microtubules [9,10]. Store depletion triggers
the release of STIM1 from these cytoskeletal structures and its trans-
location into ER-PM junctions [11–13]. Once it has reached these
junctions, STIM1 recruits Orai1 and a STIM1/Orai1 interaction oc-
curred. This interaction leads to the formation of clusters at which local
Ca2+ entry takes place [14–17]. This activation process involves as-
certainable, mechanistic steps that include STIM1 homo-/oligomeriza-
tion as well as conformational rearrangements within speciﬁc cytosolic
domains [18–20]. The latter rearrangements are accompanied by the
release and exposure of key regions (see Fig. 1), such as SOAR (STIM1-
Orai1 activation region, aa 344–442) or CAD (CRAC activation domain,
aa 342–448) which are indispensable for the STIM1-dependent acti-
vation of Orai1 channels. STIM1 binding to and communication with
Orai1 are predominantly achieved via direct interactions with their C-
terminal strands [15,21]. Stathopulos et al. subsequently characterized
this heteromeric coiled-coil formation on a structural basis by em-
ploying STIM1/Orai1 C-terminal fragments. They found that the for-
mation mainly involves the second coiled-coil domain (CC2) of STIM1
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[22].
Although the binding of STIM1 to Orai1 C-terminus is an absolute
premise, this does not seem to be suﬃcient for channel gating and the
involvement of additional domains, such as the N-terminus and the
cytosolic loop of Orai1, is still required [8,23–26]. Unlike the coupling
of STIM1 CAD/SOAR to Orai1 C-terminus, much less is known about
other regions within STIM1 that accomplish Orai1 gating [27].
In this study, we focus on the role of a small helical domain (i.e.
alpha3) within STIM1 CAD/SOAR (see scheme in Fig. 1) that is crucial
for Orai1 activation. This region is shown to contribute to the trans-
mission of a gating signal from STIM1 to Orai1, as deletions or speciﬁc
mutations therein result in abolished Orai1 currents. Interestingly,
these STIM1 α3 mutants still bind to Orai1, but they fail to trigger Orai1
channel gating. The crosslinking of cysteines introduced in STIM1 α3
and the cytosolic Orai1 TM3 region resulted biochemically in the for-
mation of a STIM1-Orai1 complex and in the stimulation of Orai1
channel currents. These results suggest that these regions are close to
each other and are functionally essential for gating signal transmission.
The results of the current study show that the SOGI formed between
STIM1 α3 and Orai1 TM3 plays a crucial role in that it allows STIM1
binding to be relayed into Orai1 channel activation.
2. Results
2.1. The STIM1 α3 domain is necessary for Orai1 activation
To examine the role of the α3 region (aa 400–403) in STIM1 (see
scheme in Fig. 1), we initially deleted the whole domain (STIM1 Δα3)
to characterize its functional impact. This deletion fully abolished the
capability of STIM1 to activate Orai1 currents (Fig. 1A). However, the
propensity to form clusters was not aﬀected, as STIM1 Δα3 was still
able to form punctae in response to TG-induced store depletion when
expressed without Orai1 (Fig. 1B). Homomerisation of STIM1 Δα3 both
without and with Orai1 was only slightly reduced compared to that
observed for STIM1 WT, as evaluated with FRET measurements
(Fig. 1C),
Next, we examined whether STIM1 Δα3 was still able to couple to
Orai1. Unfortunately, our initial attempts to perform FRET experiments
were hampered. We hypothesized that this was due to the reduced af-
ﬁnity of STIM1 Δα3 to Orai1, which potentially originated from steric
interference of the required C-terminal STIM1 Δα3 labelling. This hy-
pothesis was supported by the observation that the co-localization of
the C-terminally labelled STIM1 Δα3 with Orai1 was substantially re-
duced compared to the co-localization of the N-terminally labelled
STIM1 Δα3 (Fig. 1D). Thus, we used the degrees of co-localization
(Pearson coeﬃcient) observed between the full-length N-terminally
labelled STIM1 forms and Orai1 as semi-quantitative measures of their
Fig. 1. The STIM1 α3 domain is necessary for Orai1 activation.
A time course of whole cell, inward currents at−74mV, activated by passive store depletion of HEK293 cells expressing Orai1 WT together with either STIM1 WT or
STIM1 Δα3 (Δaa400–403). B ﬂuorescence images of Y-STIM1 WT and Y-STIM1 Δα3 before and after application of 1 μM TG. Lengths of scale bars correspond to
5 μm. C time course of FRET (Eapp) monitoring the homomerization of the respective C/Y-labelled STIM1 constructs mentioned in A in response to 1 μM TG in the
presence and absence of Orai1 WT. D calculated Pearson-coeﬃcient (R-value) as a quantitative measurement of co-localization between the indicated C-STIM1 and Y-
Orai1 mutants compared to WT before and after treatment with 1 μM TG. With STIM1 Δα3, co-localization of both the N-terminally (C-S1Δα3) and the C-terminally
(S1Δα3-C) labelled forms are depicted. (number of cells are indicated within each bar). E ﬂuorescence images of representative cells (CFP-green, YFP-red) after
treatment with 1 μM TG as well as an overlay (merge) for visual comparison. Focused to the bottom section of the cell with a lengths of scale bars corresponding to
5 μm.
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coupling eﬃciencies.
STIM1 Δα3 and STIM1 WT co-localized equally with Orai1 (Fig. 1D,
E). STIM1 Δα3 did not co-localize with Orai1 L273D, which was ex-
pected, as the introduction of this C-terminal point mutation has been
shown to fully disrupt STIM1 binding to Orai1 [16,28](Fig. 1D, E). To
further investigate the implications of the co-localization regarding the
interactions between STIM1 forms and Orai1, we utilized a C-terminally
shortened fragment of STIM1 (STIM11-535 Δα3) [29]. The fact that the
polybasic cluster at the very end of the STIM1 C-terminus was speciﬁ-
cally deleted prevented STIM11-535 Δα3 cluster formation in the ab-
sence of Orai1 (Fig. 1E, bottom row). In contrast, STIM11-535 Δα3
clearly showed the same degrees of co-localization and cluster forma-
tion with co-expressed Orai1 as STIM1 WT (Fig. 1D, E). These ﬁndings
suggested that the overall interaction of N-terminally labelled, full-
length STIM1 with Orai1 was not aﬀected by the α3 domain deletion.
To further investigate the implications of co-localization, we used
the smallest, Orai1-activating STIM1 fragment (i.e. a CAD/SOAR-like
region (aa 344–449)) in an ER-tethered form to mimic the ER locali-
zation of a full-length STIM1 (Supp-Fig. 1A). To prevent steric inter-
ference, the ﬂuorophore was luminally linked to the N-terminus in a
construct (TMG-CAD) that we derived using our recently established
FIRE-system [20]. Again, we observed that the degree of co-localization
between TMG-CAD Δα3 and Orai1 was comparable to that seen with
TMG-CAD WT (Supp-Fig. 1C, D), but TMG-CAD Δα3 failed to con-
stitutively activate Orai1 currents (Supp-Fig. 1B). Taken together, these
results demonstrated that STIM1 Δα3 exhibited homomerisation,
punctae formation and speciﬁc co-localization with Orai1 upon store
depletion to a similar extent as STIM1 WT. Our results also showed,
however, that STIM1 Δα3 failed to induce CRAC currents, suggesting
that STIM1 Δα3 was not able to eﬀectively elicit Orai1 gating.
Because Orai1 activation was severely impacted when the whole
STIM1 α3 helix was deleted, we subsequently deleted individual amino
acids within this region (STIM1 Δ400, STIM1 Δ401, STIM1 Δ402,
STIM1 Δ403, see scheme in Fig. 2). Every single amino acid deletion
impaired Orai1 activation (Fig. 2A), despite the fact that each STIM1
mutant remained co-localized with Orai1 (Fig. 2B). These ﬁndings led
us to investigate the potential impact of the helicity of the whole α3
region. It is known that the presence of poly-alanines favours, while
poly-glycines weaken, the helical propensity [30]. For this reason, we
ﬁrst mutated the whole α3 region to alanines (STIM1 400AAAA403). We
observed that the degree of co-localization with Orai1 and Orai1 acti-
vation were comparable to those seen with STIM1 WT (Fig. 2C, D).
When we mutated the whole α3 region to glycines (STIM1
400GGGG403), however, Orai1 activation was completely abolished
(Fig. 2C), although slightly diminished but still robust co-localization
was observed (Fig. 2D).
These results suggested that the α3 region as a whole entity with its
helical structure was required to elicit the STIM1-dependent gating of
the Orai1 channel. We then conducted an additional aspartate screen
within the alanine mutant (STIM1 400AAAA403). This revealed that all
STIM1 mutants (STIM1 400DAAA403, STIM1 400ADAA403, STIM1
400AADA403, STIM1 400AAAD403) co-localized with Orai1 like STIM1
WT, regardless of the position of the aspartate within the α3 domain
(Fig. 2D). Aspartates placed at positions 400, 401 and 403 did not in-
terfere with Orai1 activation, though Orai1 currents obtained with
STIM1 400DAAA403 as well as STIM1 400ADAA403 and STIM1
400AAAD403 were reduced and enhanced, respectively, compared to the
currents obtained with STIM1 WT (Fig. 2C). Strikingly, STIM1
400AADA403, which had an aspartate at position 402, failed to activate
Orai1 currents (Fig. 2C), despite the fact that the co-localization with
Orai1 was retained (Fig. 2D).
These ﬁndings led us to more closely examine residue L402, and we
subsequently substituted it with several diﬀerent amino acids. We dis-
covered that the store-operated currents for these mutants were com-
parable to those seen for STIM1 WT if small and uncharged amino acids
were inserted at this position (STIM1 L402 A, STIM1 L402S) (Fig. 2E). If
larger or positively charged residues were inserted (STIM1 L402Q,
STIM1 L402 K), Orai1 was also activated, but to a lower extent than
with STIM1 WT (Fig. 2E). The extent of co-localization with Orai1 for
all these mutants was comparable to that seen with STIM1 WT or
slightly reduced (Fig. 2F). Interestingly, when we introduced a negative
charge at position 402 (STIM1 L402D, STIM1 L402E), we could abolish
Orai1 activation, despite the fact that reduced but still pronounced co-
localization was observed (Fig. 2E, F).
Our earlier attempt to use FRET as a complimentary approach to
examine the extent of co-localization between Orai1 and full-length
STIM1 α3 mutants had not been successful. For this reason, we used N-
terminally labelled CAD/SOAR mutants (CAD Δα3, CAD L402D) in-
stead and assessed these for their aﬃnity to Orai1 by performing FRET
and patch clamp measurements. In addition, we utilized 2-APB to
promote an association between CAD forms and Orai1, as this method
has been successfully established by Wang et al. [27]. We examined
whether this association was accompanied by an additional increase in
the potential transient current. These CAD α3 mutants exhibited a re-
duced aﬃnity and FRET with Orai1 (Supp-Fig. 2A, B), but reached le-
vels that were close to those of WT CAD upon application of 2-APB
(Supp-Fig. 2A, B).
In the corresponding patch clamp experiments, CAD WT showed
constitutive currents that were increased in a transient manner upon 2-
APB application, as expected (Supp-Fig. 2C, D). However, no con-
stitutive currents were evoked with the CAD α3 mutants, and only
minor current enhancements were observed following the application
of 2-APB (Supp-Fig. 2C, D). These minor functional responses were
divergent from the pronounced increases observed in the aﬃnity and
FRET of these mutants to Orai1. Consistent electrophysiological results
were obtained for full-length STIM1 WT and the STIM1 α3 mutants
following 2-APB application. Only minor current enhancements were
observed for the gating-deﬁcient STIM1 α3 mutants, while large tran-
sient current increases were observed with STIM1 WT (Supp-Fig. 2E, F).
Taken together, these results suggested that the STIM1 α3 region
moderately aﬀected the aﬃnity between STIM1 and Orai1, but still
represented a key domain in the process that led to Orai1 channel
gating.
2.2. Partially open Orai1 P245L restores the gating propensity of STIM1 α3
mutants
Next, we tested whether the constitutively active Orai1 P245L
mutant [31–34] could compensate for the gating defect related to the
Orai1 channel activation process observed for the STIM1 α3 mutants.
We assumed that Orai1 P245L was already constitutively active and
that a partially open state existed upon starting whole-cell recording.
This constitutive activity was further enhanced following store deple-
tion in a STIM1-dependent manner (Fig. 3A). We consistently observed
that the additional current enhancement was strictly dependent on the
coupling between STIM1 and Orai1 P245L (Fig. 3B, C). The increase in
both the current and extent of co-localization was abolished upon the
mutational disruption of the main STIM1 binding site on the Orai1 C-
terminus, i.e. Orai1 L273D (Fig. 3A–C).
The co-expression of Orai1 P245L with either of the gating-deﬁcient
STIM1 α3 mutants also resulted in the activation of Orai1 P245L cur-
rents following store-depletion (Fig. 3D, G) to the same level seen for
STIM1 WT (Fig. 3A). This co-expression was accompanied by an extent
of co-localization for STIM1 Δα3 that was comparable to that of Orai1
WT (Fig. 3E, F) and was slightly higher than that of STIM1 L402D
(Fig. 3F, H). The I/V-relationship of both mutants displayed a char-
acteristic, strong inward rectiﬁcation with a reversal potential> +
50mV, which was comparable to that seen for STIM1 WT-induced
currents (Fig. 3I). We assumed that the regain of Orai1 P245L gating
observed for the STIM1 α3 mutants was the result of a mechanism that
was distinct from one that was recently reported [35] for the non-
functional STIM1 F394H and R429C mutants. These mutants failed to
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co-localize with and activate Orai1 WT, but the activation could be
restored by the Orai1 P245L mutation, primarily due to an increase in
the mutant STIM1 binding to Orai1 P245 L [35]. These ﬁndings were
corroborated by the discovery that Orai1 P245L has a higher aﬃnity
towards STIM1, revealed by the results of localization experiments in
which the STIM1 C-terminus was utilized as a cytosolic fragment in
Orai1 or Orai1 P245L co-expressing cells (Supp-Fig. 4A, B). We did not
believe that the gating propensity of the STIM1 α3 mutants was re-
stored by the small increase in their aﬃnity with Orai1 P245L, as
suggested from the slight increase in co-localization of STIM1 α3 mu-
tants and Orai1 P245L when compared to Orai1 WT (Fig. 3E, H). In-
stead, we hypothesized that the constitutively active Orai1 P245L
channel mutant provides a trigger signal that allows the transmission of
STIM1 coupling into gating of the Orai1 WT channels, and this signal is
lacking in the STIM1 α3 mutants.
2.3. Orai1 E173K restores the gating deﬁciency of STIM1 α3 mutants
Data recently published by Zhou et al. [36] suggest that the hinge
region in TM4 and the C-terminal cytosolic helical extension of TM4
(TM4-ext) of Orai1, as well as the neighbouring TM3, play key roles in
the Orai1 channel activation process. The main interaction with STIM1
is mediated by the Orai1 C-terminus [15,37]. The degree of co-locali-
zation indicated that this interaction was similar for STIM1 WT and
STIM1 α3 mutants. Hence, we hypothesized that the lack of Orai1
gating observed in STIM1 α3 mutants could be due to an impairment in
Fig. 2. Mutational screen in STIM1 α3.
A time course of whole cell inward currents at
−74mV activated by passive store depletion
of HEK293 cells, expressing Orai1 WT together
with either STIM1 WT or STIM1 α3 single de-
letion mutants. B calculated Pearson-coeﬃ-
cient (R-value) as a quantitative measurement
of co-localization for the constructs measured
in A before and after treatment with 1 μM TG
(number of cells are indicated within each
bar). C time course of whole-cell, inward cur-
rents at −74mV, activated by passive store
depletion of HEK293 cells expressing Orai1 WT
together with either STIM1 WT or STIM1 α3
multiple-point mutants. D calculated Pearson-
coeﬃcient (R-value) as a quantitative mea-
surement of co-localization for the constructs
measured in C before and after treatment with
1 μM TG (number of cells are indicated within
each bar). E time course of whole-cell, inward
currents at−74mV, activated by passive store
depletion of HEK293 cells expressing Orai1 WT
together with either STIM1 WT or STIM1 L402
mutants. F calculated Pearson-coeﬃcient (R-
value) as a quantitative measurement of co-
localization for the constructs measured in E
before and after treatment with 1 μM TG
(number of cells are indicated within each
bar).
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the transmission of STIM1 coupling into Orai1 gating via TM3. Here,
the presence of the STIM1 α3 domain might support the gating signal
relay from Orai1 TM4/TM4-ext to TM3 L174 [36].
To test this hypothesis experimentally, we ﬁrst engineered Orai1
TM3 L174 K and TM3 L174D mutants and examined their potential
activation with both STIM1 WT and STIM1 α3 mutants. These forms of
STIM1 were not able to activate Orai1 L174 K or Orai1 L174D (Fig. 4A,
Supp-Fig. 3B). These results are consistent with a general, profound
block of STIM1-induced Orai1 activation reported in [38]. Next, we
extended the search to the more upstream cytosolic portion of Orai1
TM3 (residues 166–173, see Supp-Fig. 3A) in an attempt to rescue the
Orai1 function in the presence of STIM1 Δα3 and STIM1 L402D. We
initially mutated residue E166, which is located closest to the cytosol
and points toward the TM4-ext (Supp-Fig. 3A) (E166Q, E166 K), and
residue E173, which is adjacent to L174 (E173Q and E173K). These
Orai1 mutants were still activated by STIM1 WT (Supp-Fig. 3C, left
panel) and exhibited degrees of co-localization that were comparable to
that with Orai1 WT (Supp-Fig. 3D, left panel). When co-expressed with
STIM1 L402D, these Orai1 mutants revealed a substantial degree of co-
localization (Supp-Fig. 3D, right panel), and Orai1 E166Q – but not
Orai1 E166K – and Orai1 E173Q yielded extremely small store-oper-
ated currents. Strikingly, only Orai1 E173K was substantially activated
by STIM1 L402D in a store-dependent manner (Supp-Fig. 3C, right
panel). Moreover, both STIM1 Δα3 and STIM1 L402D showed clear
store-dependent activations of Orai1 E173K currents, although these
were observed to a lower extent as compared with STIM1 WT (Fig. 4B).
These currents also exhibited strong inward rectiﬁcation and a reversal
potential that was similar to those obtained with STIM1 WT (Fig. 4C).
As both α3 mutants showed degrees of co-localization with Orai1
E173K (Fig. 4D, E) that were comparable to that observed with Orai1
WT (Figs. 1D, 2 F), we concluded that the activation of the Orai1 E173K
current was not due to an increase in the aﬃnity to the STIM1 forms.
The STIM1 C-terminus consistently showed a similar aﬃnity to Orai1
E173K and Orai1 WT (Supp-Fig. 4C, D). Overall, these experiments
suggested that Orai1 E173K apparently provided part of the gating
signal which is usually provided by the STIM1 α3 domain.
2.4. Close proximity of STIM1 α3 and Orai1 TM3
The results reported in the previous section suggest that an interplay
Fig. 3. Partially open Orai1 P245 L restores
gating propensity of STIM1 α3 mutants.
A time course of whole-cell, inward currents at
−74mV, activated by passive store depletion
of HEK293 cells expressing Orai1 P245L as
well as Orai1 P245L L273D together with
STIM1 WT. Orai1 P245L alone is shown as a
control (orange). B calculated Pearson-coeﬃ-
cient (R-value) as a quantitative measurement
of co-localization between the indicated Y-
Orai1 mutants and C-STIM1 WT. Orai1 WT
(grey) was taken as a control. C corresponding
ﬂuorescence images for visual comparison.
Focused to the bottom section of the cell with a
lengths of scale bars corresponding to 5 μm. D
time course of whole-cell, inward currents at
−74mV, activated by passive store depletion
of HEK293 cells expressing STIM1 Δα3 to-
gether with either Orai1 WT (black) or Orai1
P245L (red). E co-localization corresponding to
measurements in D (number of cells are in-
dicated within each bar). F ﬂuorescence
images corresponding to measurements in E
and H. Focused to the bottom section of the cell
with a lengths of scale bars corresponding to
5 μm. G time course of whole-cell, inward
currents at−74mV, activated by passive store
depletion of HEK293 cells expressing STIM1
L402D together with either Orai1 WT (black)
or Orai1 P245 L (red). H co-localization corre-
sponding to measurements in G (number of
cells are indicated within each bar). I I/V re-
lationship of Orai1 P245L co-expressed with
either STIM1 WT, STIM1 Δα3 or STIM1 L402D.
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occurs between STIM1 α3 and Orai1 TM3 which is necessary for Orai1
channel opening. To identify the STIM1 α3 target site on Orai1 TM3,
we carried out cysteine crosslinking experiments to determine whether
these two domains were close to each other. Taking a straightforward
approach, we mutated STIM1 L402 and a potential interaction partner
at the cytosolic end of TM3 (E162, E166, R170, E173; see Fig. 5A) to a
cysteine. To prevent the involvement of other endogenous cysteines in
STIM1/Orai1, we also mutated a potentially interfering cysteine residue
that was located in the C-terminus of STIM1 (C437S), and we created an
Orai1 variant that lacked all three endogenous cysteines (Orai1 C126V
C143V C195V: Orai1cys-free). In line with earlier studies of [39], we
found that the co-expression of Orai1cys-free and STIM1 WT yielded only
very low currents (Supp-Fig. 5E). The currents obtained for Orai1cys-free
and STIM1 C437S were similar in size and did not alter when the cy-
steine-crosslinking reagent diamide was added (Supp-Fig. 5F).
We observed a robust co-localization with STIM1 L402C C437S for
all Orai1cys-free TM3 mutant forms following store depletion, although
the degree of co-localization was somewhat elevated in some of these
Orai1cys-free TM3 forms before store depletion (Fig. 5B). We conducted
patch-clamp recordings of the Orai1cys-free TM3 mutants, revealing
small, store-dependent, inward currents that were similar to those seen
with Orai1cys-free activated by STIM1 L402C C437S (Fig. 5C). When
diamide was applied in an attempt to potentially crosslink the re-
spective cysteine residue of Orai1 TM3 with STIM1 L402C, we noted
that the current only increased in the case of Orai1cys-free E166C, while
the remaining mutants (E162C, R170C, E173C) collectively failed to
show enhanced responses (Fig. 5C). The I/V-relationship of the dia-
mide-induced currents displayed strong inward rectiﬁcation with a re-
versal potential of around+ 50mV (Supp-Fig. 5B). When taking a
biochemical approach, the results of cysteine crosslinking experiments
with store-depleted HEK293 STIM1/Orai1 double knockout cells, ana-
lysed using a STIM1/Orai1 western blot, revealed complex formations
between expressed Orai1cys-free E166C and STIM1 L402C C437S pro-
teins upon treatment with diamide. These ﬁndings suggested a close
proximity between STIM1 α3 and Orai1 TM3 (Fig. 5D, Supp-Fig. 6A).
The additional band was observed only when STIM1 L402C C437S and
Orai1cys-free E166C were co-expressed and diamide treatment was per-
formed. These bands were exactly the same sizes on Orai1- and STIM1-
antibody-detected blots (Fig. 5D and Supp-Fig. 6A), respectively.
This recognition by both Orai1- and STIM1-speciﬁc antibodies in-
dicated that both proteins were present in a covalently linked STIM1-
Orai1 complex. The molecular weight of the complex (between 200 and
250 kDa) did not allow us to deduce its stoichiometry, as it neither
matched that of 1 STIM1/1 Orai1 (˜160 kDa), nor 2 STIM1/1 Orai1
(˜260 kDa). We suspected this was due to an anomalous migration be-
haviour [40] of the covalently linked STIM1-Orai1 complex. Further-
more, the diamide-induced Ca2+ current increase observed in patch-
clamp recordings made with Orai1cys-free E166C and STIM1 L402C
C473S was fully reversible upon the application of bis(2-mercaptoethyl)
sulfone (BMS). This reagent is known to disrupt cysteine crosslinking
(Fig. 5C insert, Supp-Fig. 5C). This reversibility was also veriﬁed by the
results of Western blots, using the diamide-treated samples, upon the
addition of BMS (Supp-Fig. 6B).
To exclude the possibility that the current enhancement observed
with Orai1cys-free E166C was caused by crosslinking between neigh-
bouring Orai1 subunits, we co-expressed this mutant together with
STIM1 C437S instead of STIM1 L402C C437S. The addition of diamide
did not result in a signiﬁcant increase in the Ca2+ currents (Supp-
Fig. 5D), which provided supportive evidence. In a second approach,
we additionally mutated all other residues in STIM1 α3 to a cysteine
(STIM1 S400C C437S, STIM1 S401C C437S, STIM1 D403C C437S). We
then co-expressed each of these mutants with Orai1cys-free E166C. The
extent of co-localization seen with Orai1cys-free E166C was only slightly
lower for L401C and D403C and similar to that seen for the S400C or
L402C STIM1 C437S mutants (Fig. 5E). One interesting result was that
only STIM1 L402C C437S displayed current enhancement upon the
application of diamide (Fig. 5F). Overall, these functional and bio-
chemical data provided compelling evidence, allowing us to conclude
that STIM1 α3 and Orai1 TM3 are close to one another. These data also
suggest that an interface exists between these two domains or nearby
residues, i.e. SOGI, that allows the transmission of STIM1 coupling into
Orai1 channel gating.
Fig. 4. Orai1 E173K restores the gating deﬁeciency of STIM1 α3 mutants.
A time course of whole-cell, inward currents at −74mV, activated by passive store depletion of HEK293 cells expressing Orai1 L174K together with STIM1 WT,
STIM1 L402D, or STIM1 Δα3. B time course of whole-cell, inward currents at−74mV, activated by passive store depletion of HEK293 cells expressing Orai1 E173K
together with STIM1 WT/STIM1 Δα3/STIM1 L402D. C I/V relationship of measurements in B. D co-localization corresponding to measurements in B. E corresponding
ﬂuorescence images for visual comparison. Focused to the bottom section of the cell with a lengths of scale bars corresponding to 5 μm.
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3. Discussion
Our study on the small helical domain (α3) within the CAD/SOAR
region of STIM1 reveal its major impact on the activation of store-op-
erated Ca2+ entry. We identiﬁed the speciﬁc, functional role of STIM1
α3 in CRAC channel activation by deleting or individually mutating
residues within this domain. The results show that STIM1 α3 is a dis-
crete domain that plays a key role in relaying STIM1 coupling into
Orai1 channel opening. Cysteine crosslinking of STIM1 with Orai1
functionally resulted in Ca2+ current enhancement. This crosslinking
could be biochemically visualized in the formation of a STIM1/Orai1
complex by Western blotting, pointing to the fact that the cytosolic part
of the Orai1 TM3 region might be a target site for STIM1 α3. Overall,
this observed close proximity between STIM1 α3 and Orai1 TM3 sug-
gests the presence of a STIM1-Orai1 gating interface (SOGI) that facil-
itates Orai1 channel gating upon STIM1 coupling.
The STIM1 α3 domain does not play a dominant role in store-de-
pletion-induced STIM1 homomerisation and co-clustering with Orai1,
both of which are prerequisites for Orai1 activation by STIM1. When
co-expressed with Orai1, the degree of homomerisation of STIM1 Δα3
was comparable to that seen for STIM1 WT. Although the aﬃnity for
STIM1 Δα3 to Orai1 was slightly reduced, the perturbance was not as
dominant as that seen for a previously reported STIM1 mutation within
the upstream α2 region (i.e. STIM1 F394 H) [27]. Despite the fact that
the features of STIM1 activation were preserved, Orai1 activation was
abolished with STIM1 Δα3, indicating that the STIM1 α3 domain, in a
direct or indirect manner, inﬂuenced the transmission of a gating signal
that aﬀects Orai1 channel opening.
We conducted a mutational screen, deleting each individual residue
within the α3 region. This allowed us to identify fully or almost fully
gating-deﬁcient STIM1 deletion mutants that retained extents of co-
localization with Orai1 that were similar to that seen for STIM1 WT.
When we substituted the whole α3 region to alanines (STIM1
400AAAA403), no eﬀect on the co-localization with Orai1 was observed;
current levels that were similar to that seen with STIM1 WT were also
seen. However, when we mutated the whole α3 region to glycines
(STIM1 400GGGG403), thereby weakening the helical structure, we
abolished channel activation despite the fact that the extent of co-lo-
calization with Orai1 was only slightly diminished.
Taken together, these results suggest that the α3 region – as a whole
entity with the inherent helical structure – is essential for gating signal
transmission within the Orai1 channel. Based on these results, we
cannot exclude the possibility that the STIM1 α3 region has an indirect,
allosteric eﬀect. Nonetheless, we identiﬁed position 402 (STIM1
400AADA403) by conducting an aspartate screen within STIM1
400AAAA403 as the most eﬀective one. This position was similar to
STIM1 Δα3 in that it interfered with the activation of Orai1 without
strongly aﬀecting the extent of co-localization. An additional screen at
Fig. 5. Close proximity of STIM1 α3 and Orai1 TM3.
A model of dOrai generated via PyMOL. Amino acids within the cytosolic TM3 region, which are putative candidates for crosslinking with STIM1 L402C are
highlighted in diﬀerent colours. B calculated Pearson-coeﬃcient (R-value) as a quantitative measurement of co-localization between the indicated Orai1 mutants and
STIM1 L402C C437S before and after treatment with 1 μM TG (number of cells are indicated within each bar). C time course of whole-cell, inward currents at
−74mV, activated by passive store depletion of HEK293 cells expressing STIM1 L402C C437S together with the following Orai1cys-free mutants: WT (black), E162C
(orange), E166C (red), R170C (green) and E173C (blue), the time point of diamide application is indicated by the bar. The insert shows the reversibility of the
diamide induced crosslinking by application of BMS as indicated by the arrow. D representative Western Blot of crosslinking experiments overexpressing YFP or CFP
labelled Orai1 and/or STIM1 constructs in STIM1/Orai1 double knockout HEK293 cells detected with an antiOrai1 antibody. Upon store-depletion with TG, samples
were treated without or with 1mM diamide. Bands at ∼60 kDa correspond to Orai1 monomers. Bands at ∼120 kDa correspond to Orai1 dimers. A STIM1-Orai1
aggregate can only be seen in STIM1 L402C C437S/Orai1cys-free E166C co-expressed, diamide-treated samples. Experiments were repeated at least 3 times with
individual transfections. E calculated Pearson-coeﬃcient (R-value) as a quantitative measurement of co-localization between Orai1cys-free E166C and the indicated
STIM1 mutants before and after treatment with 1 μM TG (number of cells are indicated within each bar). F time course of whole-cell, inward currents at −74mV,
activated by passive store depletion of HEK293 cells expressing Orai1cys-free E166C and STIM1 L402C C437S. The reversibility of the diamide eﬀect is shown by
application of BMS as indicated by the bars.
C. Butorac, et al. Cell Calcium 79 (2019) 57–67
63
position 402 within STIM1 α3 revealed that speciﬁcally substituting the
native amino acid at this position with negatively charged amino acids
(D, E) fully abolished Orai1 channel activation but led to only a slight,
yet signiﬁcant, reduction in the extent of co-localization with Orai1.
This decrease in aﬃnity became even more apparent when we
created CAD α3 mutants that exhibited reduced levels of aﬃnity as well
as reduced FRET with Orai1. When we utilized 2-APB [27] to sub-
stantially restore the aﬃnity and FRET with the gating-deﬁcient STIM1
α3 mutants (STIM1 L402D, STIM1 Δα3), we observed only minor
current enhancements. These signiﬁcantly diﬀered from the huge,
transient current increases obtained when WT STIM1 or STIM1 F394H
were used [27]. The latter STIM1 F394H mutant has been reported as
unable to bind to or activate Orai1, but both its aﬃnity to and activa-
tion of Orai1 can be restored by adding 2-APB. We could restore this
aﬃnity in our mutants, and especially our CAD α3 mutants, by adding
2-APB as well, but could not (or only to a minor extent) restore the
activation of Orai1, showing that the α3 domain is necessary to elicit
Orai1 gating.
We carefully examined the results of the detailed mutational screen,
focusing on the STIM1 Δα3 and STIM1 L402D mutants to characterize
their gating defects in more detail. We utilized the partially open Orai1
P245L channel mutant as a tool to determine whether the defect in
gating was caused by deletion of α3 or whether the L402D mutation
therein had a more severe, inhibitory impact on STIM1. Since both
STIM1 α3 mutants were able to elicit store-dependent inward currents
with Orai1 P245L in a manner similar to STIM1 WT, this suggested the
presence of a functional deﬁciency that allowed the transmission of
STIM1 binding into the Orai1 WT pore opening rather than a deﬁciency
in the initial binding process itself.
We then proposed that the P245L mutation could allow for a higher
aﬃnity of STIM1 binding and observed a higher aﬃnity of binding
between the STIM1 C-terminus and Orai1 P245L. The degree of co-lo-
calization of STIM1 α3 mutants, and in particular of the L402D mutant,
with Orai1 P245L was indeed slightly higher than that seen for Orai1
WT, but was comparable and equal to that of STIM1 WT. For this
reason, we considered it more likely that Orai1 P245L was able to
compensate for the lack of a gating trigger signal in STIM1 α3 mutants,
allowing them to transmit their coupling into Orai1 gating. It is
tempting to speculate that the Orai1 P245L mutation may have an
impact on the TM4/TM4-ext region, which has been proposed to hy-
drophobically link the TM4 nexus region to the adjacent TM3, thus
aﬀecting the signal propagation towards TM1 and eliciting pore
opening [36]. In the case of Orai1 WT, the TM3 or at least a certain
region within TM3 could represent an acceptor site for STIM1 α3.
We tested this hypothesis initially by conducting a mutational
screen within the more cytosolic portion of Orai1 TM3 to examine its
impact on the STIM1-gating-deﬁcient α3 mutants. We were indeed able
to identify the Orai1 E173K mutant that substantially restored the ac-
tivity of either gating-deﬁcient STIM1 α3 mutant, although not to the
full extent as seen for STIM1 WT. Unlike Orai1 P245L, the overall af-
ﬁnity of the STIM1 C-terminus to Orai1 E173K was comparable to its
aﬃnity to Orai1 WT. These results are in line with the extents of co-
localization seen for STIM1 α3 mutants, which showed similarly high
levels with either Orai1 WT or Orai1 E173K. Thus, it seemed as though
Orai1 E173K provided part of the transmitting signal input that was
otherwise provided by the STIM1 α3 domain. This residue is adjacent to
L174 in Orai1 TM3, which plays a role in TM3/TM4 signal propagation
[36]. Its mutation severely interferes with STIM1-dependent activation.
As the activation levels of Orai1 WT or Orai1 E173K currents induced
by STIM1 WT did not exhibit signiﬁcant diﬀerences, we cannot infer
that residue E173 in Orai1 itself represents a speciﬁc acceptor site for
STIM1 α3. Moreover, the Orai1 residues upstream E173 in TM3 are
considered to be more accessible to STIM1 when it approaches from the
cytosolic side [41].
In an attempt to speciﬁcally identify the proximity between STIM1
α3 and Orai1 TM3, we carried out cysteine crosslinking studies with
STIM1/Orai1 mutants that were devoid of endogenous cysteines and
expressed them in a HEK293 STIM1/Orai1 double-knockout cell line.
The results of these experiments revealed a close proximity between
STIM1 L402C and E166C in the Orai1 cytosolic TM3. This proximity
allowed biochemically for the formation of a STIM1/Orai1 complex and
resulted functionally in a substantial Ca2+ current increase upon ap-
plication of diamide. We are well aware of the fact that the introduction
of cysteines may induce non-physiological interactions. Nonetheless, a
number of studies have been carried out in the STIM/Orai ﬁeld in
which such experiments have been successfully used to obtain further
structural information on close proximity (Orai pore: McNally et al.,
PNAS, 2009; Zhou et al, PNAS 2010; Orai1 TM3/TM4 nexus: Zhou
et al., Nat Comm, 2016; STIM1 activation: Hirve et al, Cell Rep, 2018).
We have recently reported [42] that a decrease in currents observed
in cysteine crosslinking studies on Orai1 K78C E166C suggests that a
communication pathway exists between K78 in TM1 and E166 in TM3.
This somewhat inhibitory communication might be released by the
enforced engagement of E166C in Orai1 with L402C in STIM1. Re-
cently, the structure of the constitutively active Drosophila Orai H206 A
(equivalent to H134 A in human Orai1) [43] mutant was reported [44].
This structure suggests an unlatching of TM4 and between TM4 and
TM3 as prerequisites to open the pore and expose cytosolic docking
sites for STIM1. Based on our results, we propose that the Orai1 cyto-
solic TM3 stretch (between E173 and E166) is involved in the formation
of a STIM1 Orai1 gating interface (SOGI) that relays a molecular trigger
from the STIM1 α3 domain to elicit CRAC channel gating. As we cannot
fully exclude that STIM1 alpha3 might serve as a passive structural
component rather than as a direct actor in positioning a diﬀerent sur-
face of STIM1 for signal transmission to Orai1, our hypothesis of SOGI
as physiological contact site awaits further proof once the STIM1/Orai1
complex has been structurally resolved.
4. Experimental procedures
4.1. Molecular cloning and mutagenesis
Human Orai1 (Orai1; accession no. NM_032790) was provided by A.
Rao’s Laboratory, Harvard Medical School. N-terminally tagged Orai1
constructs were cloned with SalI and SmaI restriction sites of pECFP-C1
and pEYFP-C1 expression vectors (Clontech). Orai1 mutants (P245 L,
P245 L L273D, E166Q, E166 K, E173Q, E173 K, C126 V C143 V C195 V
(cys-free), cys-free E166C, cys-free E162C, cys-free R170C, cys-free
E173C) were generated using the QuikChange XL site-directed muta-
genesis kit (Stratagene).
Human STIM1 (STIM1; accession no. NM_003156) N-terminally
tagged with enhanced CFP (ECFP) and enhanced yellow ﬂuorescent
protein (EYFP) was provided by T. Meyer’s Laboratory, Stanford
University. STIM1 C terminus (amino acids 233–685) was cloned into
the T/A site of pcDNA3.1V5 His TOPO by PCR and subcloned into
pECFP-C1 and pEYFP-C1 via their internal restriction sites KpnI and
XbaI. Construct for the FIRE system consists of STIM1-signal peptide,
EYFP (Y), 29-aa linker, STIM1 transmembrane domain, 32-glycine
linker followed by the protein fragment of interest (CAD 344–449).
STIM1 mutants (L402D, Δ400-403, Δ400, Δ401, Δ402, Δ403, L402A,
L402K, L402Q, L402S, L402E, 400AAAA403, 400DAAA403, 400ADAA403,
400AADA403, 400AAAD403, 400GGGG403, C437S, L402C C437S, S400C
C437S, S401C C437S, D403C C437S) were generated using the
QuikChange XL site-directed mutagenesis kit (Stratagene). The integrity
of all resulting clones was conﬁrmed by sequence analysis.
4.2. Cell culture and transfection
Human embryonic kidney 293 (HEK293) cells were cultured in
DMEM supplemented with L-glutamine (2mM), streptomycin (100 μg/
ml), penicillin (100 units/ml) and 10% foetal calf serum at 37 °C in a
humidity-controlled incubator with 5% CO2. Transient transfection of
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HEK293 cells was performed using the TransFectin Lipid Reagent (Bio-
Rad). Measurements were carried out 24 h following transfection.
4.3. Generation of STIM1/Orai1 double knockout HEK293 cells using
CRISPR/Cas9 genome editing
The guide RNA pairs within exon 1 of STIM1 were identiﬁed using
the Benchling CRISPR webtool (https://benchling.com/crispr) and the
following complementary oligos with BbsI compatible overhangs were
designed:
STIM1_gRNA1 for: 5′-CAC CGT TCT GTG CCC GCG GAG ACT C-3′
STIM1_gRNA1 rev: 5′-AAA CGA GTC TCC GCG GGC ACA GAA C-3′
STIM1_gRNA2 for: 5′-CAC CGT ATG CGT CCG TCT TGC CCT G-3′
STIM1_gRNA2 rev: 5′-AAA CCA GGG CAA GAC GGA CGC ATA C-3′
The oligo pairs were annealed by incubating for 5min at 95 °C in a
thermocycler and then ramping down to 25 °C at 5 °C/min. The dsDNA
guide inserts were ligated into BbsI-digested p× 330.pgkpuro vector
[45]. HEK293 cells seeded in a 6-well plate were co-transfected with
1 μg of each plasmid using Lipofectamine® 2000 (Thermo Fisher Sci-
entiﬁc) when the cells were 50–60% conﬂuent. The transfectants were
subjected to 96 h of puromycin selection (1.5 μg/ml), 24 h after trans-
fection.
For further knockout of Orai1, the guide RNA pairs within exon 2
and exon 3 were identiﬁed using the Benchling CRISPR webtool and the
following complementary oligos with BbsI compatible overhangs were
designed:
Exon 2:
Orai1_gRNA1 for: 5′-CAC CGA TCG GCC AGA GTT ACT CCG-3′
Orai1_gRNA1 rev: 5′-AAA CCG GAG TAA CTC TGG CCG ATC-3′
Exon3:
Orai1_gRNA2 for: 5′-CAC CGG CGG AGT TTG CCC GCT TAC-3′
Orai1_gRNA2 rev: 5′-AAA CGT AAG CGG GCA AAC TCC GCC-3′
The oligo pairs were annealed as mentioned above. The dsDNA
guide inserts with BbsI overhangs were ligated into BbsI-digested pU6-
(BbsI) CBh-Cas9-T2 A-mCherry (Addgene Plasmid #64324). The re-
sulting constructs were co-transfected in HEK293 STIM1 KO cells
seeded in a T25 ﬂask using Lipofectamine 2000. The transfected cells
were FACS-sorted with mCherry ﬂuorescence, and single cells were
seeded in a 96-well plate. The cells were tested by Ca2+ imaging with
FURA-2 and a single-cell-derived clone, F4, was functionally conﬁrmed
to have undergone knockout of STIM1 and Orai1 (Supp-Fig. 7). Cells
were used until passage 18.
4.4. Electrophysiology
Electrophysiological experiments were performed using the patch-
clamp technique in whole-cell recording conﬁgurations at 21–25 °C. An
Ag/AgCl electrode was used as reference electrode. Voltage ramps were
applied every 5 s from a holding potential of 0 mV, covering a range of
−90mV to+90mV over 1 s. For passive store depletion the internal
pipette solution included (in mM): 145 Cs methane sulfonate, 20 EGTA,
10 HEPES, 8 NaCl, 3,5 MgCl2, pH 7.2. Standard extracellular solution
consisted of (in mM) 145 NaCl, 10 HEPES, 10 CaCl2, 10 glucose, 5 CsCl,
1 MgCl2, pH 7.4. A liquid junction potential correction of+ 12mV was
applied, resulting from a Cl−-based bath solution and a sulfonate-based
pipette solution. All currents were leak subtracted either by subtracting
the initial voltage ramps obtained shortly following break-in with no
visible current activation, or with constitutively active currents after
application of 10 μm La3+ at the end of the experiment. All experiments
were carried out at least on two diﬀerent days.
4.5. Confocal FRET ﬂuorescence microscopy
Confocal FRET microscopy was performed on HEK293 cells, as
previously described [46]. In brief, a QLC100 Real-Time Confocal
System (VisiTech Int.) connected to two Photometrics CoolSNAPHQ
monochrome cameras (Roper Scientiﬁc) and a dual port adapter (di-
chroic: 505lp; cyan emission ﬁlter: 485/30; yellow emission ﬁlter: 535/
50; Chroma Technology Corp.) was used for recording ﬂuorescence
images. This system was attached to an Axiovert 200M microscope
(Zeiss, Germany) in conjunction with two diode lasers (445 nm,
515 nm) (Visitron Systems). Image acquisition and control of the con-
focal system was performed with a Visiview 2.1.1 software (Visitron
Systems). Image correction due to cross-talk and cross-excitation were
performed prior to the calculation. Therefore, appropriate cross-talk
calibration factors were determined for each construct on each day of
the FRET experiment. After threshold determination and background
subtraction, the corrected FRET (Eapp) was calculated on a pixel-to-pixel
basis using a custom-made software [46] integrated in MatLab 7.0.4
according to the method published by Zal and Gascoigne [47], with a
microscope-speciﬁc constant G value of 2.0. All experiments were
performed at room temperature. The Pearson correlation coeﬃcient (R-
value) was used to measure the strength of the linear association/co-
localization between STIM1 and Orai1 variants, where a value R=1
meant a perfect positive correlation/co-localization.
4.6. Cell preparation, diamide-crosslinking and western blot analysis
HEK293 STIM1/Orai1 double KO cells cultured in 12-cm dishes
were transfected with 5 μg plasmid using Transfectin lipid reagent
(Biorad) following the manufacturer’s instructions. 24 h after transfec-
tion, cells were treated with 1 μM TG solution [1 μM TG in 0mM Ca2+
extracellular solution] for 3min at room temperature. After TG in-
cubation, cells were treated with 1mM diamide-solution for 5min at
room temperature, and the reaction was stopped upon addition of
50mM N-ethylmaleimide quenching solution. Cells were then har-
vested and washed twice in an HBSS (Hank’s balanced salt solution)
buﬀer containing 1mM EDTA. After centrifugation (1000 g/2min), cell
pellets were resuspended in homogenization buﬀer [25mM Tris HCl pH
7.4, 50mM NaCl, protease inhibitor (Roche)] and incubated on ice for
15min. Lysed cells were passed 10 times through a 27 G ½” needle and
centrifuged at 1000 g for 15min at 4 °C to pellet debris. 21 μl of each
sample were mixed with nonreducing Laemmli’s buﬀer, heated 15min
at 55 °C and subjected to 3–8% Tris-acetate gels (BioRad). For breaking
up the disulphide bonds, samples were treated 10min with BMS.
Separated proteins were transferred to a nitrocellulose membrane and
immunoblotted with an antibody recognizing STIM1 (Cell signalling
technology) or Orai1 (Sigma Aldrich), respectively. Each experiment
was performed at least three independent times.
4.7. Statistics
The results are depicted as means ± s.e.m. determined for the in-
dicated number of experiments. For statistical comparison, the
Student’s two-tailed t test was applied. * p < 0.05 always in correla-
tion to WT.
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